Corticosteroid co-medication does not reduce the incidence and severity of neurotoxicity induced by docetaxel

1998-11-20

Anti-Cancer Drugs , Volume 9 - Issue 9 p. 759- 764

Additional Metadata
Keywords	Corticosteroids, Docetaxel, Neuropathy
Persistent URL	doi.org/10.1097/00001813-199810000-00003, hdl.handle.net/1765/70415
Journal	Anti-Cancer Drugs
Organisation	Department of Neurology
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Pronk, L.C, Hilkens, P.H.E, van den Bent, M.J, van Putten, W.L.J, Stoter, G, & Verweij, J. (1998). Corticosteroid co-medication does not reduce the incidence and severity of neurotoxicity induced by docetaxel. Anti-Cancer Drugs, 9(9), 759–764. doi:10.1097/00001813-199810000-00003

Publication